Cargando…
Towards Antibiotic Synthesis in Continuous-Flow Processes
Continuous-flow chemistry has become a mainstream process and a notable trend among emerging technologies for drug synthesis. It is routinely used in academic and industrial laboratories to generate a wide variety of molecules and building blocks. The advantages it provides, in terms of safety, spee...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919330/ https://www.ncbi.nlm.nih.gov/pubmed/36771086 http://dx.doi.org/10.3390/molecules28031421 |
_version_ | 1784886798072152064 |
---|---|
author | Comito, Marziale Monguzzi, Riccardo Tagliapietra, Silvia Palmisano, Giovanni Cravotto, Giancarlo |
author_facet | Comito, Marziale Monguzzi, Riccardo Tagliapietra, Silvia Palmisano, Giovanni Cravotto, Giancarlo |
author_sort | Comito, Marziale |
collection | PubMed |
description | Continuous-flow chemistry has become a mainstream process and a notable trend among emerging technologies for drug synthesis. It is routinely used in academic and industrial laboratories to generate a wide variety of molecules and building blocks. The advantages it provides, in terms of safety, speed, cost efficiency and small-equipment footprint compared to analog batch processes, have been known for some time. What has become even more important in recent years is its compliance with the quality objectives that are required by drug-development protocols that integrate inline analysis and purification tools. There can be no doubt that worldwide government agencies have strongly encouraged the study and implementation of this innovative, sustainable and environmentally friendly technology. In this brief review, we list and evaluate the development and applications of continuous-flow processes for antibiotic synthesis. This work spans the period of 2012–2022 and highlights the main cases in which either active ingredients or their intermediates were produced under continuous flow. We hope that this manuscript will provide an overview of the field and a starting point for a deeper understanding of the impact of flow chemistry on the broad panorama of antibiotic synthesis. |
format | Online Article Text |
id | pubmed-9919330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99193302023-02-12 Towards Antibiotic Synthesis in Continuous-Flow Processes Comito, Marziale Monguzzi, Riccardo Tagliapietra, Silvia Palmisano, Giovanni Cravotto, Giancarlo Molecules Review Continuous-flow chemistry has become a mainstream process and a notable trend among emerging technologies for drug synthesis. It is routinely used in academic and industrial laboratories to generate a wide variety of molecules and building blocks. The advantages it provides, in terms of safety, speed, cost efficiency and small-equipment footprint compared to analog batch processes, have been known for some time. What has become even more important in recent years is its compliance with the quality objectives that are required by drug-development protocols that integrate inline analysis and purification tools. There can be no doubt that worldwide government agencies have strongly encouraged the study and implementation of this innovative, sustainable and environmentally friendly technology. In this brief review, we list and evaluate the development and applications of continuous-flow processes for antibiotic synthesis. This work spans the period of 2012–2022 and highlights the main cases in which either active ingredients or their intermediates were produced under continuous flow. We hope that this manuscript will provide an overview of the field and a starting point for a deeper understanding of the impact of flow chemistry on the broad panorama of antibiotic synthesis. MDPI 2023-02-02 /pmc/articles/PMC9919330/ /pubmed/36771086 http://dx.doi.org/10.3390/molecules28031421 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Comito, Marziale Monguzzi, Riccardo Tagliapietra, Silvia Palmisano, Giovanni Cravotto, Giancarlo Towards Antibiotic Synthesis in Continuous-Flow Processes |
title | Towards Antibiotic Synthesis in Continuous-Flow Processes |
title_full | Towards Antibiotic Synthesis in Continuous-Flow Processes |
title_fullStr | Towards Antibiotic Synthesis in Continuous-Flow Processes |
title_full_unstemmed | Towards Antibiotic Synthesis in Continuous-Flow Processes |
title_short | Towards Antibiotic Synthesis in Continuous-Flow Processes |
title_sort | towards antibiotic synthesis in continuous-flow processes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919330/ https://www.ncbi.nlm.nih.gov/pubmed/36771086 http://dx.doi.org/10.3390/molecules28031421 |
work_keys_str_mv | AT comitomarziale towardsantibioticsynthesisincontinuousflowprocesses AT monguzziriccardo towardsantibioticsynthesisincontinuousflowprocesses AT tagliapietrasilvia towardsantibioticsynthesisincontinuousflowprocesses AT palmisanogiovanni towardsantibioticsynthesisincontinuousflowprocesses AT cravottogiancarlo towardsantibioticsynthesisincontinuousflowprocesses |